In the Center for Antibody Technologies, we strive to use scientific research to solve problems around the world. For this reason, several companies have been started by members or alumni from the group. A list of companies started by members or alumni from the group while they were affiliated with the research group is listed below.
ComboTopes Therapeutics (2023), www.combotopetherapeutics.com

Combotope Therapeutics ApS is a biotech company (CRO) that develops antibodies against combotopes (combined glycotopes and epitopes), primarily for therapeutic purposes (e.g., therapeutic antibodies and CAR-T/M therapies).
– Dr. Klas Ola Blixt
– Dr. Søren Nyboe Jakobsen
– Andreas H. Laustsen
Agrobiomics ApS (2022), www.agrobiomics.bio

Agriobiomics is a BioAg company harnessing the power of soil bacteria and their metabolites as new biostimulants to help crops cope with abiotic stress such as drought.
– Andreas H. Laustsen
– Jonas A. Jürgensen
VenomAid Diagnostics ApS (2018), www.venomaid.com

VenomAid Diagnostics ApS is a biotech and
– Andreas H. Laustsen
– Cecilie Knudsen
– Rasmus U. W. Friis
– Søren Helweg Dam
– Aleksander M. Haack
– Jonas A. Jürgensen
Bactolife ApS (2017), www.bactolife.com

Bactolife ApS is a biotech company developing protein-based products for prevention and treatment of gastrointestinal infections.
– Andreas H. Laustsen
– Sandra W. Thrane
Chromologics ApS (2017), www.chromologics.com

– Andreas H. Laustsen
Antag Therapeutics ApS (2017), www.antagtherapeutics.com

Antag Therapeutics ApS is a biotech company developing biotherapeutics against metabolic diseases.
– Andreas H. Laustsen
VenomAb IVS (2013-2018)

VenomAb IVS was a biotech company aiming towards developing novel snakebite antivenoms based on human monoclonal antibodies.
– Andreas H. Laustsen
– Mikael Engmark
Biosyntia ApS (2012), www.biosyntia.com

Biosyntia ApS is a biotech company developing bacterial fermentation solutions for fine and specialty chemicals and novel screening systems based on synthetic biology.
– Andreas H. Laustsen